85% below the July peak of last year and 99% below its all-time high.
Orbiting a major support level around $4.
A capital injection began in mid-November that is still not properly reflected in price.
Stochastic at the oversold point and RSI close to touching it.
It could give the surprise of giving a significant bounce to the marked lines.
The risk is that...
Breaking through the double top barrier, HBIO is now gathering support around the previous resistance level. The stock has been in a steady accumulation stage with a strong uptrend and increasing volume. The strong uptrend should continue. The Benchmark Company has also changed their status from a Speculative Buy to a Buy, as of today. There is enough volume to...